The thrombotic thrombocytopenia syndrome (TTS), a complication of COVID-19 vaccines,
involves thrombosis (often cerebral venous sinus thrombosis) and thrombocytopenia with …

Introduction To combat COVID-19, scientists all over the world have expedited the process
of vaccine development. Although interim analyses of clinical trials have demonstrated the …

Background A new clinical syndrome has been recognized following the COVID-19 vaccine,
termed thrombosis with thrombocytopenia syndrome (TTS). The following systematic review …

Background: Thrombosis with thrombocytopenia syndrome (TTS) has been reported among
individuals vaccinated with adenovirus-vectored COVID-19 vaccines. In this study, we …

Background Current vaccines for the Coronavirus Disease of 2019 (COVID-19) have
demonstrated efficacy with low risk of adverse events. However, recent reports of thrombosis …

The amazing effort of vaccination against COVID-19, with more than 2 billion vaccine doses
administered all around the world as of 16 June 2021, has changed the history of this …

Thrombotic Thrombocytopenia Syndrome (TTS) has emerged as a new adverse event
following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus …

Safety and efficacy of vaccines against the SARS-CoV-2 coronavirus has been
demonstrated in clinical trials and next by their real world use through the course of the …

Historically, the vaccination strategies developed in the second half of the 20th century have
facilitated the eradication of infectious diseases. From the onset of COVID-19 pandemic to …

Introduction With the advent of COVID-19 vaccines, hospitalization rates and progression to
severe COVID-19 disease have reduced drastically. Most of the adverse events reported by …